Patents-Review.com
ClassID:

110421 ⎘

C12N2740/16271 - CPC Classification

Classification description:

Reverse transcribing RNA viruses; Details; Retroviridae; Human Immunodeficiency Virus, HIV concerning HIV gagpol Demonstrated effect

Recent Application in this class:
#1
20250360199
2025-11-27

IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE

 #2
20240277829
2024-08-22

HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION

 #3
20230173056
2023-06-08

PERSISTENT MEMORY T-CELL RESPONSES TO CANCER AND INFECTIOUS-DISEASE ANTIGENS BY MANIPULATION OF AMINO ACID-CATABOLISM PATHWAYS

 #4
20220112245
2022-04-14

CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS

 #5
20210269486
2021-09-02

CHIMPANZEE ADENOVIRUS CONSTRUCTS WITH LYSSAVIRUS ANTIGENS

 #6
20200397890
2020-12-24

Antiviral vaccines with improved cellular immunogenicity

 #7
20190381166
2019-12-19

Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions

 #8
20190314492
2019-10-17

Antiviral vaccines with improved cellular immunogenicity

 #9
20190247491
2019-08-15

Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

 #10
20190201522
2019-07-04

Optimized HIV envelope gene and expression thereof

 #11
20190142937
2019-05-16

Vaccines with biomolecular adjuvants

 #12
20180346520
2018-12-06

METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE USING CONSERVED ELEMENT CONSTRUCTS

 #13
20180333481
2018-11-22

Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

 #14
20180064803
2018-03-08

Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

 #15
20170360920
2017-12-21

METHOD AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF A HIV INFECTION

 #16
20170258891
2017-09-14

Optimized HIV envelope gene and expression thereof

 #17
20170239344
2017-08-24

Antiviral vaccines with improved cellular immunogenicity

 #18
20170112922
2017-04-27

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

 #19
20170043009
2017-02-16

Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent

 #20
20170028056
2017-02-02

Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions

 #21
20160237123
2016-08-18

Compositions and methods comprising hydrocarbon-stapled polypeptides

 #22
20160067334
2016-03-10

Vaccines with biomolecular adjuvants

 #23
20160024156
2016-01-28

Antiviral vaccines with improved cellular immunogenicity

 #24
20150056237
2015-02-26

Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conserved regions

 #25
20120076812
2012-03-29

Antiviral vaccines with improved cellular immunogenicity

 #26
20110318352
2011-12-29

Compositions and methods for the treatment of viral infections

 #27
20110200636
2011-08-18

Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen

 #28
20090214588
2009-08-27

Vaccines against aids comprising cmv/r-nucleic acid constructs